ESRRA facilitates hepatocellular carcinoma progression through transcriptional activation of PHF5A and serves as a potential therapeutic target of rosuvastatin
ESRRA facilitates hepatocellular carcinoma progression through transcriptional activation of PHF5A and serves as a potential therapeutic target of rosuvastatin. // Cellular Signalling. – URL: https://www.sciencedirect.com/science/article/pii/S0898656826006613?dgcid=rss_sd_all
ESRRA facilitates hepatocellular carcinoma progression through transcriptional activation of PHF5A and serves as a potential therapeutic target of rosuvastatin. Cellular Signalling. https://www.sciencedirect.com/science/article/pii/S0898656826006613?dgcid=rss_sd_all
“ESRRA facilitates hepatocellular carcinoma progression through transcriptional activation of PHF5A and serves as a potential therapeutic target of rosuvastatin.” Cellular Signalling.
@article{article40091,
title = {ESRRA facilitates hepatocellular carcinoma progression through transcriptional activation of PHF5A and serves as a potential therapeutic target of rosuvastatin},
journal = {Cellular Signalling},
url = {https://www.sciencedirect.com/science/article/pii/S0898656826006613?dgcid=rss_sd_all}
}